Related Experiment Video
Updated: Aug 19, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation
Jae Won Joh1, Hwan Hyo Lee, Dae Sung Lee
1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract:
In order to evaluate whether immunosuppressive agents such as mycophenolate mofetil (MMF) and azathioprine would differently influence the outcome of the renal transplants, we prospectively analyzed the incidence of acute rejection episodes, cytomegalovirus infection within the first 6 months following renal transplantation and 5 yr graft survival rate after minimizing influences of donor factors by grafting the same cadaveric donor kidney. There was no significant difference in sex, HLA mismatch, cold ischemic time, and patients' weight between the two groups. Contrary to the previous studies which demonstrated that MMF could lower the incidence of acute rejection episodes and improved graft survival rate, the two groups showed no significant difference in the incidence of acute rejection episodes and 5-yr graft survival rate as well. This discrepancy in these results might explain that donor factors could be important to cadaveric renal transplantation. Thus, we suggest that the influences of donor factors should be considered in further clinical studies of cadaveric renal transplantation.
Insights
This study found no significant difference in kidney transplant outcomes between mycophenolate mofetil (MMF) and azathioprine. Donor factors, not immunosuppressive agents, may significantly impact renal transplant success.
Area of Science:
- Nephrology
- Immunosuppression
- Transplant Surgery
Background:
- Immunosuppressive agents are crucial for renal transplant success.
- Mycophenolate mofetil (MMF) and azathioprine are commonly used immunosuppressants.
- Previous studies suggest MMF improves outcomes compared to azathioprine.
Purpose of the Study:
- To compare the efficacy of MMF and azathioprine in renal transplantation.
- To evaluate the impact of these agents on acute rejection and graft survival.
- To investigate the role of donor factors in transplant outcomes.
Main Methods:
- Prospective analysis of renal transplant recipients.
- Comparison between MMF and azathioprine treatment groups.
- Standardized donor kidney selection to minimize donor-specific variables.
Main Results:
- No significant difference in acute rejection episodes between MMF and azathioprine groups.
- No significant difference in 5-year graft survival rates between the two groups.
- Identified potential influence of donor factors on transplant outcomes.
Conclusions:
- MMF and azathioprine showed similar efficacy in this cohort.
- Donor factors may play a more critical role than previously recognized in cadaveric renal transplantation.
- Future studies should account for donor variability in renal transplantation research.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management
